Note to readers referred here from the Oct. 20 NY Times story "Steps to Greater Accountability in Medical Education" by Duff Wilson:
This is a multi-author blog. The essay "Nemeroff, Seroquel, and ACCME" by Dr. Bernard Carroll is at this link on the blog.
Kratom’s potential for good would be jeopardized by DEA ban - A move to make kratom a Schedule 1 controlled substance would make it extremely difficult for researchers to fully examine its safety and clinical uses.
55 minutes ago